Reuters logo
BRIEF-Trump nominee to lead FDA testifies before U.S. Senate committee
April 5, 2017 / 4:57 PM / 8 months ago

BRIEF-Trump nominee to lead FDA testifies before U.S. Senate committee

April 5 (Reuters) -

* U.S. Food and Drug Administration nominee Dr. Scott Gottlieb says he believes opportunities exist for clinical trials that “don’t require the tight randomization” current clinical trials do.

* Gottlieb says he would be willing to “speak truth to power” to argue if needed that there is “no causal link” between vaccines and autism.

* Gottlieb says opioid addiction epidemic is a public health emergency “on the order of Ebola and Zika.”

* Gottlieb says he is “uniquely qualified” to prevent companies from using “regulatory arbitrage” to gain commercial advantage.

* Gottlieb says certain flavored vaping or e-cigarette products “might be inappropriate in one context and not in another.” Source text for Eikon: Further company coverage: [ ] (Reporting by Toni Clarke)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below